DOPAVIEW 222 MBq/ml, solution for injection bottle, 15 ml
Active ingredients: Fluorodopa F-18
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injectionbottle, 15 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DOPAVIEW 222 MBq/mL, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 15 ml
- Marketing authorisation holder
- ADVANCED ACCELERATOR APPLICATIONS MOLECULAR IMAGING FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 24 Feb 2016
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Prescribed by specialists only
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63099647CIP75501036CIP133400955010364Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FLUORODOPA [18F]solution | 222 MBq · 1 ml de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.